Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Treatment with a combined endothelin A/B-receptor antagonist does not prevent chronic renal allograft rejection in rats.

Braun C, Conzelmann T, Vetter S, Schaub M, Back WE, Kirchengast M, Tullius SG, Schnülle P, van der Woude FJ, Rohmeiss P. Treatment with a combined endothelin A/B-receptor antagonist does not prevent chronic renal allograft rejection in rats. J Cardiovasc Pharmacol. 2000 Oct; 36(4):428-37.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.